Amlodipine And Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 50228-366

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Amlodipine And Olmesartan Medoxomil (NDC 50228-366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (10 mg/40 mg (30 Tablet Bottle))

Label for Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg film-coated oral tablets. The label details that each tablet contains amlodipine 10 mg and olmesartan medoxomil 20 mg. Package contains 1,000 tablets, manufactured by ScieGen Pharmaceuticals, Inc. Storage instructions and barcode are also shown.*

FDA Label Image

Package Label-principal Display Panel (10 mg/40 mg (30 Tablet Bottle))

Label for Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg by ScieGen Pharmaceuticals, Inc. The film-coated tablets contain 10 mg amlodipine and 20 mg olmesartan medoxomil. The label indicates storage instructions, quantity of 30 tablets, and includes the NDC 50228-367-30 barcode and manufacturer information.*

FDA Label Image

Package Label-principal Display Panel (10 mg/40 mg (30 Tablet Bottle))

Label for Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg strength, film-coated oral tablets. The label indicates a package containing 90 tablets, with storage instructions and manufacturer details for ScieGen Pharmaceuticals, Inc., located in Hauppauge, NY. The label includes a barcode and mentions the NDC 50228-367-90.*

FDA Label Image

Package Label-principal Display Panel (10 mg/40 mg (30 Tablet Bottle))

Label for Amlodipine and Olmesartan Medoxomil Tablets 10 mg/40 mg film-coated oral tablets. The label states each tablet contains 10 mg amlodipine and 40 mg olmesartan medoxomil. The package contains 1,000 tablets. Manufactured by ScieGen Pharmaceuticals, Inc. Storage and dosage instructions are provided, along with a barcode and space for lot and expiration details.*

FDA Label Image

Package Label-principal Display Panel (10 mg/40 mg (30 Tablet Bottle))

Label of Amlodipine and Olmesartan Medoxomil tablets, 10 mg/40 mg strength, film-coated oral tablets. The label indicates packaging of 30 tablets, manufactured by ScieGen Pharmaceuticals, Inc. It includes storage instructions and mentions the active ingredients as amlodipine and olmesartan medoxomil. The label also shows the NDC number 50228-368-30 and barcode.*

FDA Label Image

Package Label-principal Display Panel (10 mg/40 mg (30 Tablet Bottle))

Label for Amlodipine and Olmesartan Medoxomil Tablets, strength 10 mg/40 mg. The label states each tablet contains 10 mg Amlodipine and 40 mg Olmesartan Medoxomil, with a net quantity of 90 tablets. It includes storage instructions, the NDC 50228-368-90, and is labeled Rx only. The manufacturer is ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

FDA Label Image

Package Label-principal Display Panel (10 mg/20 mg (30 Tablet Bottle))

Label for Amlodipine and Olmesartan Medoxomil Tablets 5 mg/20 mg by ScieGen Pharmaceuticals, Inc. The label states each tablet contains 5 mg amlodipine and 20 mg olmesartan medoxomil. It provides storage instructions, dosage use referral, and shows a barcode, lot and expiration placeholders, and manufacturer information.*

FDA Label Image

Package Label-principal Display Panel (5 mg/20 mg (30 Tablet Bottle))

Label for Amlodipine and Olmesartan Medoxomil Tablets 5 mg/20 mg by ScieGen Pharmaceuticals, Inc. Each tablet contains 5 mg amlodipine and 20 mg olmesartan medoxomil. The label displays dosage information, storage instructions, the NDC number, and indicates a 30 tablet count. The label also includes a barcode and manufacturer details.*

FDA Label Image

Package Label-principal Display Panel (5 mg/40 mg (30 Tablet Bottle))

Label for Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/20 mg strength, film-coated oral tablets. The label notes each tablet contains 5 mg amlodipine and 20 mg olmesartan medoxomil, with a net count of 90 tablets. It includes storage information and states the product is manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

FDA Label Image

Package Label-principal Display Panel (10 mg/40 mg (30 Tablet Bottle))

Label for Amlodipine and Olmesartan Medoxomil Tablets 5 mg/40 mg, film-coated oral tablets. The label states each tablet contains 5 mg amlodipine and 40 mg olmesartan medoxomil, with packaging for 1,000 tablets. Manufactured by ScieGen Pharmaceuticals, Inc. Includes storage instructions and barcode.*

FDA Label Image

Package Label-principal Display Panel (10 mg/40 mg (30 Tablet Bottle))

Label for Amlodipine and Olmesartan Medoxomil tablets, 5 mg/40 mg strength, film-coated oral tablets. The label lists amlodipine 5 mg and olmesartan medoxomil 40 mg as active ingredients, includes storage instructions (store at 25°C with permissible excursions), and directions to see the package insert for dosage information. It indicates a package count of 30 tablets and is manufactured by ScieGen Pharmaceuticals, Inc.*

FDA Label Image

Package Label-principal Display Panel (10 mg/40 mg (30 Tablet Bottle))

Amlodipine and Olmesartan Medoxomil Tablets 5 mg/40 mg film-coated tablets label. The label indicates each tablet contains 5 mg Amlodipine and 40 mg Olmesartan Medoxomil, with an additional note that each tablet contains 6.9 mg amlodipine besylate. The package contains 90 tablets. The label includes storage instructions, manufacturer ScieGen Pharmaceuticals, Inc., and a barcode.*

FDA Label Image

Figures 1 & 2 (Amlodipineolme Fig1 1)

A line graph illustrating the percentage of patients achieving diastolic blood pressure (DBP) under 90 mmHg plotted against baseline DBP (mmHg). The chart compares four groups: Placebo, AML 10 mg, Olmesartan Medoxomil 40 mg, and Amlodipine and Olmesartan Medoxomil tablets 10/40 mg, showing different efficacy trends in DBP reduction.*

FDA Label Image

Figures 1 & 2 (Amlodipineolme Fig1)

A line graph comparing the effects of placebo, amlodipine 10 mg, olmesartan medoxomil 40 mg, and amlodipine and olmesartan medoxomil 10/40 mg tablets on baseline systolic blood pressure (SBP) in mmHg. The graph shows the proportion of subjects with SBP below 140 mmHg over a range of baseline SBP from 140 to 180 mmHg.*

FDA Label Image

Figures 3 & 4 (Amlodipineolme Fig2 2)

A line graph comparing the percentage of subjects with diastolic blood pressure (DBP) under 80 mmHg against baseline DBP values (mmHg) across four treatments: Placebo, AML 10 mg, OM 40 mg, and Amlodipine and Olmesartan Medoxomil tablets 10/40 mg. The graph shows trends in blood pressure response for these treatments.*

FDA Label Image

Figures 3 & 4 (Amlodipineolme Fig2)

A line graph comparing the effects of placebo, olmesartan medoxomil 40 mg, amlodipine 10 mg, and amlodipine and olmesartan medoxomil tablets 10/40 mg on systolic blood pressure (SBP). The x-axis represents baseline SBP (mmHg) from 140 to 180, and the y-axis shows the percentage with SBP under 130 mmHg, ranging from 0 to 100 percent.*

FDA Label Image

Amlodipine Chemical Structure (Amlodipineolme Str1)

Chemical structure of Amlodipine and Olmesartan Medoxomil. The image shows the molecular structures of the two active ingredients used in the film-coated tablets labeled by ScieGen Pharmaceuticals, Inc.*

FDA Label Image

Olmesartan Chemical Structure (Amlodipineolme Str2)

Chemical structure diagram depicting the molecular configuration of the active ingredient Amlodipine and Olmesartan Medoxomil, showing connected atoms and bonds typical of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.